Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy

Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy

Objectives: Direct-acting antiviral agents (DAAs) have successfully eradicated chronic hepatitis C virus (HCV) infection. Since chronic HCV is known to have an increased risk of developing B cell non-Hodgkin lymphoma (B-NHL), successful HCV treatment may have virologic, hepatic, and oncologic benefi...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Myagmarjav Budeebazar, Delgerbat Boldbaatar, Khishigjargal Batsukh, Erdenetsogt Dungubat, Dagvadorj Yagaanbuyant, Naranjargal Dashdorj, Davaadorj Duger
Materialtyp: Artikel
Språk:English
Publicerad: Mongolian National University of Medical Sciences 2021-12-01
Serie:Central Asian Journal of Medical Sciences
Ämnen:
b cell non-hodgkin’s lymphoma
chemotherapy
hepatitis c virus
hepatitis flare
Länkar:https://www.mongoliajol.info/index.php/CAJMS/article/view/3011

Internet

https://www.mongoliajol.info/index.php/CAJMS/article/view/3011

Liknande verk